VYNE Therapeutics (VYNE) Change in Inventory (2019 - 2022)
VYNE Therapeutics (VYNE) posted Change in Inventory of -$97000.0 for Q1 2022, up 87.55% on a QoQ basis from -$779000.0 in Q4 2021, and down 114.1% year-over-year from $688000.0 in Q1 2021.
VYNE Therapeutics (VYNE) Change in Inventory (2019 - 2022) Analysis & Trends
VYNE Therapeutics' Change in Inventory history runs 4 years deep, the most recent figure standing at -$97000.0 for Q1 2022.
- Quarterly Change in Inventory fell 114.1% year-over-year to -$97000.0 in Q1 2022, while the trailing twelve-month figure through Dec 2022 was -$97000.0 (up 14.16% YoY) and the FY2022 annual result came in at -$97000.0, up 14.16% from the prior year.
- Change in Inventory was -$97000.0 for Q1 2022 at VYNE Therapeutics, up from -$779000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $2.6 million in Q2 2020 and bottomed at -$779000.0 in Q4 2021.
- A 4-year average of $719400.0 and a median of $721000.0 in 2020 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2020 — Change in Inventory slumped 44.4% — and 2021, when it slumped 203.32%.
- VYNE Therapeutics' Change in Inventory stood at $1.4 million in 2019, then slumped by 44.4% to $754000.0 in 2020, then slumped by 203.32% to -$779000.0 in 2021, then soared by 87.55% to -$97000.0 in 2022.
- Business Quant data shows VYNE's Change in Inventory at -$97000.0 in Q1 2022, -$779000.0 in Q4 2021, and -$209000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 71.84 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 97.70 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -26.60 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | VYNE Therapeutics | 1.19 Bn | 1.16 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -97,000.00 |
| Mar 31, 2022 | -97,000.00 |
| Dec 31, 2021 | -779,000.00 |
| Dec 31, 2021 | -779,000.00 |
| Sep 30, 2021 | -209,000.00 |
| Sep 30, 2021 | -209,000.00 |
| Jun 30, 2021 | 187,000.00 |
| Jun 30, 2021 | 187,000.00 |
| Mar 31, 2021 | 688,000.00 |
| Mar 31, 2021 | 688,000.00 |
| Dec 31, 2020 | 754,000.00 |
| Dec 31, 2020 | 754,000.00 |
| Sep 30, 2020 | 849,000.00 |
| Sep 30, 2020 | 849,000.00 |
| Jun 30, 2020 | 2.60 Mn |
| Jun 30, 2020 | 2.60 Mn |
| Mar 31, 2020 | 1.85 Mn |
| Mar 31, 2020 | 1.85 Mn |
| Dec 31, 2019 | 1.36 Mn |
| Dec 31, 2019 | 1.36 Mn |